ReviewJournal of neuroendocrinology2025

Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours.

Jelka Kuiper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.